-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Htg Molecular Diagnostics, Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to Q1 2023.
- Htg Molecular Diagnostics, Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $2.22K, a 475% increase year-over-year.
- Htg Molecular Diagnostics, Inc Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was $12.7K, a 37.9% decline year-over-year.
- Htg Molecular Diagnostics, Inc annual Income Tax Expense (Benefit) for 2022 was $10.8K, a 51.8% decline from 2021.
- Htg Molecular Diagnostics, Inc annual Income Tax Expense (Benefit) for 2021 was $22.5K, a 55.9% increase from 2020.
- Htg Molecular Diagnostics, Inc annual Income Tax Expense (Benefit) for 2020 was $14.4K, a 327% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)